Clinical Trials Directory

Trials / Completed

CompletedNCT06209476

Clinical Investigation on Assessing the Repeatability and Reproducibility of Central and Peripheral Refractive Error

Clinical Investigation on Assessing the Repeatability and Reproducibility of Central and Peripheral Refractive Error Measurement With the Grand Seiko WAM-5500

Status
Completed
Phase
Study type
Observational
Enrollment
30 (actual)
Sponsor
Johnson & Johnson Vision Care, Inc. · Industry
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

This is a unilateral, non-interventional study. Each subject will be unilaterally measured with the WAM-5500 autorefractor by 3 testers. All measurements will be made on the right eye only.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTExperimentalEligible subjects with sphere component of the subjective spherocylindrical refraction between +1.50 to -6.00D (inclusive) and 2.00D or less astigmatism in the right eye will be unilaterally measured with the WAM-5500 autorefractor by 3 testers.

Timeline

Start date
2024-01-16
Primary completion
2024-02-05
Completion
2024-02-05
First posted
2024-01-17
Last updated
2025-04-25

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06209476. Inclusion in this directory is not an endorsement.

Clinical Investigation on Assessing the Repeatability and Reproducibility of Central and Peripheral Refractive Error (NCT06209476) · Clinical Trials Directory